Effects in vivo of  -(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10,393) on platelet aggregation and blood coagulation.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D003094:Collagen / Q000037:antagonists & inhibitors; D001728:Dicumarol / Q000037:antagonists & inhibitors; D004837:Epinephrine / Q000037:antagonists & inhibitors; D000431:Ethanol / Q000097:blood / Q000494:pharmacology; D005449:Fluorenes / Q000097:blood / Q000494:pharmacology*; D006168:Guinea Pigs; D008297:Male; D010653:Phenylbutazone / Q000494:pharmacology; D010880:Piperidines / Q000097:blood / Q000494:pharmacology*; D010973:Platelet Adhesiveness / Q000187:drug effects*; D051381:Rats; D012702:Serotonin Antagonists; D013917:Thrombin / Q000037:antagonists & inhibitors
D005449:Fluorenes; D010880:Piperidines; D012702:Serotonin Antagonists; C001230:RMI 10393; D000431:Ethanol; D000244:Adenosine Diphosphate; D001728:Dicumarol; D003094:Collagen; D013917:Thrombin; D010653:Phenylbutazone; D004837:Epinephrine